Boston Scientific Corporation

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Exit or disposal costs Jul 27, 2026 8-K Other events May 18, 2026 8-K Other events May 18, 2026 8-K Amended charter or bylaws; Shareholder vote results May 5, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Results of operations (earnings release) Apr 22, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Feb 26, 2026 8-K Director or officer change; Regulation FD disclosure; Other events Feb 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Director or officer change Feb 5, 2026 8-K Results of operations (earnings release) Feb 4, 2026 8-K Entered a material agreement Jan 15, 2026 8-K Regulation FD disclosure Jan 15, 2026 8-K Director or officer change Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Director or officer change Oct 23, 2025 8-K Results of operations (earnings release) Oct 22, 2025 8-K Director or officer change Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 1, 2025 8-K Results of operations (earnings release) Jul 23, 2025 8-K Other events May 28, 2025 8-K Shareholder vote results May 6, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Director or officer change; Other events Apr 23, 2025 8-K Results of operations (earnings release) Apr 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Director or officer change Feb 12, 2025 8-K Results of operations (earnings release) Feb 5, 2025 8-K Other events Jan 16, 2025 8-K Director or officer change Nov 22, 2024 8-K Other events Nov 15, 2024 8-K Regulation FD disclosure Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release) Oct 23, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Director or officer change; Regulation FD disclosure Jul 30, 2024